PHARMANUTRA SPA (PHN.MI) Fundamental Analysis & Valuation

BIT:PHN • IT0005274094

Current stock price

67.1 EUR
-0.2 (-0.3%)
Last:

This PHN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PHN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year PHN was profitable.
  • PHN had a positive operating cash flow in the past year.
  • In the past 5 years PHN has always been profitable.
  • Each year in the past 5 years PHN had a positive operating cash flow.
PHN.MI Yearly Net Income VS EBIT VS OCF VS FCFPHN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

  • PHN has a Return On Assets of 20.17%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
  • The Return On Equity of PHN (36.55%) is better than 85.71% of its industry peers.
  • PHN's Return On Invested Capital of 25.72% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PHN is significantly above the industry average of 11.60%.
  • The 3 year average ROIC (17.21%) for PHN is below the current ROIC(25.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.17%
ROE 36.55%
ROIC 25.72%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
PHN.MI Yearly ROA, ROE, ROICPHN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • PHN has a better Profit Margin (13.39%) than 64.29% of its industry peers.
  • PHN's Profit Margin has declined in the last couple of years.
  • PHN has a better Operating Margin (21.79%) than 100.00% of its industry peers.
  • PHN's Operating Margin has been stable in the last couple of years.
  • PHN's Gross Margin of 97.13% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
  • PHN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.79%
PM (TTM) 13.39%
GM 97.13%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
PHN.MI Yearly Profit, Operating, Gross MarginsPHN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PHN.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
  • The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, PHN has less shares outstanding
  • The debt/assets ratio for PHN has been reduced compared to a year ago.
PHN.MI Yearly Shares OutstandingPHN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
PHN.MI Yearly Total Debt VS Total AssetsPHN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • PHN has an Altman-Z score of 11.04. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
  • PHN has a better Altman-Z score (11.04) than 100.00% of its industry peers.
  • The Debt to FCF ratio of PHN is 2.01, which is a good value as it means it would take PHN, 2.01 years of fcf income to pay off all of its debts.
  • PHN's Debt to FCF ratio of 2.01 is fine compared to the rest of the industry. PHN outperforms 71.43% of its industry peers.
  • PHN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.24, PHN is doing good in the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 2.01
Altman-Z 11.04
ROIC/WACC3.24
WACC7.93%
PHN.MI Yearly LT Debt VS Equity VS FCFPHN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • PHN has a Current Ratio of 2.19. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PHN (2.19) is better than 92.86% of its industry peers.
  • PHN has a Quick Ratio of 1.86. This is a normal value and indicates that PHN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of PHN (1.86) is better than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.86
PHN.MI Yearly Current Assets VS Current LiabilitesPHN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PHN.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.84% over the past year.
  • PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
  • PHN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.35%.
  • Measured over the past years, PHN shows a quite strong growth in Revenue. The Revenue has been growing by 16.59% on average per year.
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.22% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.06% on average over the next years. This is quite good.
EPS Next Y6.55%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
EPS Next 5YN/A
Revenue Next Year15.29%
Revenue Next 2Y15.09%
Revenue Next 3Y15.07%
Revenue Next 5Y12.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PHN.MI Yearly Revenue VS EstimatesPHN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
PHN.MI Yearly EPS VS EstimatesPHN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. PHN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.73, PHN can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as PHN.
  • PHN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 26.82, PHN can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, PHN is valued a bit more expensive than the industry average as 78.57% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. PHN is around the same levels.
Industry RankSector Rank
PE 26.73
Fwd PE 26.82
PHN.MI Price Earnings VS Forward Price EarningsPHN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 71.43% of the companies in the same industry are cheaper than PHN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PHN is valued more expensive than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 62.31
EV/EBITDA 14.95
PHN.MI Per share dataPHN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PHN has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PHN's earnings are expected to grow with 17.22% in the coming years.
PEG (NY)4.08
PEG (5Y)1.83
EPS Next 2Y14.68%
EPS Next 3Y17.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. PHN.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.49%, PHN has a reasonable but not impressive dividend return.
  • PHN's Dividend Yield is slightly below the industry average, which is at 2.12.
  • Compared to the average S&P500 Dividend Yield of 1.89, PHN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.49%

5.2 History

  • On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 39.70% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
  • The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.7%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
PHN.MI Yearly Income VS Free CF VS DividendPHN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M
PHN.MI Dividend Payout.PHN.MI Dividend Payout, showing the Payout Ratio.PHN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PHN.MI Fundamentals: All Metrics, Ratios and Statistics

PHARMANUTRA SPA

BIT:PHN (3/13/2026, 7:00:00 PM)

67.1

-0.2 (-0.3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)03-13
Earnings (Next)05-11
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap649.53M
Revenue(TTM)180.41M
Net Income(TTM)24.16M
Analysts82.86
Price Target83.98 (25.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.49%
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP39.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE 26.73
Fwd PE 26.82
P/S 3.6
P/FCF 62.31
P/OCF 44.95
P/B 9.83
P/tB 15.57
EV/EBITDA 14.95
EPS(TTM)2.51
EY3.74%
EPS(NY)2.5
Fwd EY3.73%
FCF(TTM)1.08
FCFY1.6%
OCF(TTM)1.49
OCFY2.22%
SpS18.64
BVpS6.83
TBVpS4.31
PEG (NY)4.08
PEG (5Y)1.83
Graham Number19.64
Profitability
Industry RankSector Rank
ROA 20.17%
ROE 36.55%
ROCE 44.34%
ROIC 25.72%
ROICexc 34.17%
ROICexgc 53.82%
OM 21.79%
PM (TTM) 13.39%
GM 97.13%
FCFM 5.78%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 2.01
Debt/EBITDA 0.37
Cap/Depr 112.59%
Cap/Sales 2.23%
Interest Coverage 250
Cash Conversion 33.69%
Profit Quality 43.15%
Current Ratio 2.19
Quick Ratio 1.86
Altman-Z 11.04
F-Score7
WACC7.93%
ROIC/WACC3.24
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
EPS Next Y6.55%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
EPS Next 5YN/A
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%
Revenue Next Year15.29%
Revenue Next 2Y15.09%
Revenue Next 3Y15.07%
Revenue Next 5Y12.06%
EBIT growth 1Y10.97%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.37%
EBIT Next 3Y20.23%
EBIT Next 5Y14.04%
FCF growth 1Y164.53%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y18.84%
OCF growth 3Y0.14%
OCF growth 5Y11.34%

PHARMANUTRA SPA / PHN.MI Fundamental Analysis FAQ

What is the fundamental rating for PHN stock?

ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.


Can you provide the valuation status for PHARMANUTRA SPA?

ChartMill assigns a valuation rating of 2 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.


What is the profitability of PHN stock?

PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.


How financially healthy is PHARMANUTRA SPA?

The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.


Is the dividend of PHARMANUTRA SPA sustainable?

The dividend rating of PHARMANUTRA SPA (PHN.MI) is 6 / 10 and the dividend payout ratio is 39.7%.